Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
02/2011
02/17/2011US20110039467 Ionic liquid flame retardants
02/17/2011US20110039109 Activator for epoxy resin compositions
02/16/2011EP2284179A2 Inhibitors of cancer cell, T-cell and keratinocyte proliferation
02/16/2011EP2284178A2 Inhibitors of cancer cell, T-cell and keratinocyte proliferation
02/16/2011EP1663105B1 Cycloalkyl heterocycles for treating hepatitis c virus
02/16/2011EP1615866B1 Indene derivatives as pharmaceutical agents
02/16/2011EP1379498B1 Sulphones which modulate the action of gamma secretase
02/16/2011CN101973941A Method for preparing 4-hydroxyphenyl hydantoin
02/16/2011CN101973940A Continuously synthesizing method of sulfonic acid alkyl group ionic liquid
02/16/2011CN101973829A Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger
02/16/2011CN101659641B Preparation method of L-carnosine zinc
02/16/2011CN101560189B Metronidazole and compound for substituting salicylic acid and preparation method and application thereof
02/15/2011US7888516 transforming growth factor (TGF- beta ) gene expression inhibitors comprising a pyrrole-imidazole polyamides, used as a therapeutic agent for diseases associated with the production of TGF- beta; drugs; side effect reduction
02/15/2011US7888515 Method for the production of N,N-carbonyldiazoles
02/15/2011US7888351 Organic compounds
02/15/2011CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
02/10/2011WO2011016559A1 Heterocyclic compound and use thereof
02/10/2011WO2011016523A1 Process for production of bis-quaternary ammonium salt, and novel intermediate
02/10/2011WO2011016501A1 Prophylactic or therapeutic agent for cancer
02/10/2011US20110034525 Nonsedating alpha-2 agonists
02/10/2011US20110034518 Pharmaceutical composition
02/10/2011US20110034513 Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production
02/10/2011US20110034483 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
02/10/2011US20110034463 Type iii secretion inhibitors, analogs and uses thereof
02/10/2011US20110033647 Novel ionic liquids, functionalized particulates, and fluoropolymer composites
02/09/2011EP2281817A1 Substituted carbinol compound having cyclic linker
02/09/2011EP2281812A1 Nitrogenous heterocyclic compound with insecticidal activity and its preparation and use
02/09/2011EP2280706A1 Lipoprotein lipase-activating compositions comprising benzene derivates
02/09/2011EP1644321B1 New benzamides as ppaty modulators
02/09/2011EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
02/09/2011CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors
02/09/2011CN101967126A Chiral leucine ion liquid
02/08/2011US7884212 deprotection of triphenylmethane(trityl)of 1-[[cyclohexyloxy) carbonyl]oxy]-ethyl-2-ethoxy-1-[[2'-(N-triphenyl-methyltetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (trityl candesartan cilexetil) in methanol and in the presence of ZnCl2
02/08/2011US7884121 Process for the preparation of phenylcarbamates
02/08/2011US7884120 microbiocides such as 2-(2-methyl-1H-indol-3-yl)-3a,11b-dihydro-1H-phenanthro[9,10-d]imidazole; bactericides; fungicides
02/08/2011US7884103 such as N-(4-Chloro-phenyl)-2-methyl-2-phenylmethanesulfonylamino-3-(4-[1,2,4]triazol-1-yl-phenoxy)-propionamide, used for controlling or preventing the infestation of plants by phytopathogenic microorganisms, especially fungi
02/08/2011CA2598156C Phosphonium and imidazolium salts and methods of their preparation
02/08/2011CA2446924C 2-iminopyrrolidine derivatives
02/03/2011WO2011014613A2 Preparation of fipamezole
02/03/2011WO2011011965A1 Luteinising hormone releasing hormone antagonist with hydantoin structure
02/03/2011US20110028733 Process for the preparation of 5-(2-ethyl-dihydro-1h-inden-2-yl)-1h-imidazole and salts thereof
02/03/2011US20110028489 Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders
02/03/2011US20110028468 Compounds having npy y5 receptor antagonistic activity
02/03/2011US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
02/03/2011DE102009035810A1 Device for the provision of a hydraulic consumer of a vehicle equipped with an armor having fluid standing under pressure for military purposes, comprises a pressure conveying device, and a prestressing unit
02/02/2011EP2279192A2 Ionic liquids
02/02/2011EP2279176A1 Novel imidazole derivatives having microbiocidal activity
02/02/2011EP2279172A2 Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions
02/02/2011EP2278878A1 2-aryl glycinamide derivatives
02/02/2011EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
02/02/2011CN1802715B Electrolytic solution for electrochemical element, method of searching for the same, method of producing the same, and electrochemical element
02/02/2011CN101962366A Diphenyl thioether linked bis-imidazoline ligand compound and preparation method thereof
02/02/2011CN101195570B Salt amino acid of ferulic acid
02/01/2011US7880017 Process for the synthesis of imidazoles
02/01/2011US7880009 Cinnamide compound
02/01/2011US7879896 Dual-acting imidazole antihypertensive agents
02/01/2011US7879886 such as N-benzyl-N-hydroxy-2-(3-hydoxypyridin-2-ene)-1,3-thiazolidine-4-carboxamide, used for reducing the population of Plasmodium in a human infested with Plasmodium protozoans and suffering from malaria
02/01/2011US7879863 Aniline derivatives
02/01/2011CA2555633C Non-nucleoside reverse transcriptase inhibitors
02/01/2011CA2502633C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
01/2011
01/27/2011WO2011010619A1 Diamine compound, polyamic acid, polyimide, and liquid crystal aligning agent
01/27/2011US20110021573 Antagonists of prostaglandin d2 receptors
01/27/2011US20110021448 Inhibitors for the Soluble Epoxide Hydrolase
01/26/2011EP2277848A1 Indene derivatives as pharmaceutical agents
01/26/2011EP2276745A1 Ruthenium olefin metathesis catalysts bearing n-heterocyclic carbene ligands with substituted backbone
01/26/2011EP1675833B1 1h-imidazole derivatives as cannabinoid receptor modulators
01/26/2011EP1554239B1 Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
01/26/2011CN101959882A 咪唑羰基化合物 Imidazole-carbonyl compound
01/26/2011CN101959803A Method for water purification, equipment for water purification, and water purification set
01/26/2011CN101955768A Surfactant used for displacement of reservoir oil, preparation method and application thereof in tertiary oil recovery
01/26/2011CN101955462A Fenticonazole nitrate, preparation of levorotatory form and dextrorotatory form and application of levorotatory form in preparing antifungal medicaments
01/26/2011CN101239951B 1-(2,3-dihydroxypropyl)-2-methyl-5-nitroimidazole compound and its preparation method and use
01/25/2011US7875645 2-(2-cyclopropyl-benzyl)-4,5-dihydro-1H-imidazole; depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder, stress-related disorders, psychotic disorders such as schizophrenia, neurological diseases such as Parkinson's disease, neurodegenerative disorders
01/25/2011US7875631 e.g.1-(3,5-dichlorophenyl)-2-formyl-6-methoxy-1,2,3,4-tetrahydroisoquinoline; to prevent and/or treat cancer and other abnormal cell growth, and metabolic as well as blood vessel proliferate disorders, in which uncontrolled expression of insulin-like growth factor-1 receptor is observed
01/25/2011CA2589329C Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
01/25/2011CA2404125C Sulphonamido-substituted bridged bicycloalkyl derivatives
01/20/2011WO2011007899A1 Glycine transporter inhibitors
01/20/2011WO2011007819A1 Pharmaceutical product containing lactam or benzene sulfonamide compound
01/20/2011WO2011006903A1 Substituted triazole and imidazole derivatives as gamma secretase modulators
01/20/2011WO2010120370A3 Gamma-amino-butyric acid derivatives as gabab receptor ligands
01/20/2011US20110015389 1,3 imidazolidine derivatives and their use in the production of carbapenem
01/20/2011US20110015371 Inhibitors of interleukin-1 beta converting enzyme
01/20/2011US20110015360 Dithiocarbamic esters
01/20/2011US20110015246 Lofexidine enantiomers for use as a treatment for cns disease and pathologies and its chiral synthesis
01/20/2011CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators
01/19/2011EP2275411A2 Reformatsky Reagent in Stable Form and Process for Producing the Same
01/19/2011EP2275395A2 Copper-catalyzed formation of carbon-carbon bonds
01/19/2011EP2274287A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
01/19/2011EP2274284A2 Fungicidal substituted azoles
01/19/2011CN201711151U Metronidazole hydroxylation reaction kettle
01/19/2011CN101948435A Preparation method of 5-chlorine-1-methyl-4-nitro iminazole
01/19/2011CN101948434A Chiral tyrosine radical ionic liquid
01/19/2011CN101193866B Process for the synthesis of 5- (methyl-1H-imidazol-1-yl) -3- (trifluoromethyl) -benzeneamine
01/19/2011CN101052638B 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
01/18/2011US7872139 Heteroaryl-ureas and their use as glucokinase activators
01/18/2011US7871960 1-(Imidazolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
01/18/2011CA2500964C Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
01/13/2011WO2011005969A2 Etomidate analogues that do not inhibit adrenocortical steroid synthesis
01/13/2011WO2011005959A1 Process for the preparation of n-protected-decylaminoethanal
01/13/2011WO2011004384A2 Process for the preparation of eprosartan
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 345